Burden, trends and projections of liver cancer in China and G20 countries: a comparative study based on the global burden of disease database 2021
Due to the implementation of preventive strategies, advancements in healthcare, and improved economic conditions, the incidence, prevalence, mortality, and DALYs of liver cancer in China have decreased. However, there remains a certain gap compared to G20 countries at the same time. In the future, China should develop more detailed prevention and control strategies targeting risk factors, tailored to men, women, and different age groups.
Authors
- Yu-Pei Wu
- Bingnan Ren (ORCID: https://orcid.org/0000-0003-2651-1637)
- Yinling Ma (ORCID: https://orcid.org/0000-0001-7752-6201)
- Wei He (ORCID: https://orcid.org/0000-0002-3503-8530)
- Jing An (ORCID: https://orcid.org/0000-0003-0885-8979)
- Huizhen Wu
- Yifan He (ORCID: https://orcid.org/0000-0002-2227-6847)
- Jian-qun Zhao
- Ya-meng Liu
Institutions
- Hebei Medical University (CN)
- Second Hospital of Hebei Medical University (CN)
- Hebei General Hospital (CN)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2026-01-16
- DOI
- https://doi.org/10.3389/fpubh.2025.1668750
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Washington
- Institute for Health Metrics and Evaluation